<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00001194</url>
  </required_header>
  <id_info>
    <org_study_id>840058</org_study_id>
    <secondary_id>84-CC-0058</secondary_id>
    <nct_id>NCT00001194</nct_id>
  </id_info>
  <brief_title>NMR Scanning on Patients</brief_title>
  <official_title>NMR Scanning on Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institutes of Health Clinical Center (CC)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      This protocol is designed to investigate the use of novel techniques in MRI that may not yet
      be commercially available. Specifically, the protocol enables patients to take advantage of
      new pulse sequence software, coil design or post processing capabilities not otherwise
      available. The informed consent explains MRI in lay terms, describes the use of contrast
      agents and lists contraindications to MRI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      NMR imaging promises to provide useful and unique diagnostic information in a variety of
      diseases. In an attempt to evaluate its role, we plan to study a wide range of diseases
      during the initial year of imaging. Exposure to magnetic fields and radiofrequency energies
      of this magnitude have demonstrated no deleterious effects clinically or in the laboratory.
      The only restrictions will be those imposed by ferromagnetic objects within the patient which
      would increase the risk of placing them in a strong magnetic field.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 1984</start_date>
  <completion_date>February 2001</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <enrollment>99999</enrollment>
  <condition>Diagnostic Imaging</condition>
  <eligibility>
    <criteria>
      <textblock>
        Any patient undergoing MRI for research or clinical purposes who is participating in a
        currently active NIH protocol.

        No patients with pacemakers, cochlear implants, implanted pumps, shrapnel, metal in the
        globe of the eye, cerebral aneurysm clips or other contraindication to MRI.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Warren G. Magnuson Clinical Center (CC)</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Choyke PL, Walther MM, Wagner JR, Rayford W, Lyne JC, Linehan WM. Renal cancer: preoperative evaluation with dual-phase three-dimensional MR angiography. Radiology. 1997 Dec;205(3):767-71.</citation>
    <PMID>9393533</PMID>
  </reference>
  <reference>
    <citation>Niendorf HP, Dinger JC, Haustein J, Cornelius I, Alhassan A, Clauss W. Tolerance data of Gd-DTPA: a review. Eur J Radiol. 1991 Jul-Aug;13(1):15-20. Review.</citation>
    <PMID>1889423</PMID>
  </reference>
  <verification_date>March 2000</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 1999</study_first_submitted>
  <study_first_submitted_qc>December 9, 2002</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2002</study_first_posted>
  <last_update_submitted>March 3, 2008</last_update_submitted>
  <last_update_submitted_qc>March 3, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2008</last_update_posted>
  <keyword>Helium Cryogen</keyword>
  <keyword>Magnetic Field</keyword>
  <keyword>Multi-Institute</keyword>
  <keyword>Nitrogen Cryogen</keyword>
  <keyword>Radiofrequency</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

